Aging Analytics agency is leveraging cutting-edge machine learning techniques to offer high tech startups and venture investors a better option when they are seeking additional capital for completing a financial round. Due to exponential advancements in computer processing power, IT technology and state of art analytics, the process of making investment decisions happens today at high speed. This allows companies to spend more time on the research that is fundamental to their technology, products and services, rather than on market research.
Aging Analytics is a strategic consulting company dedicated to improving the efficacy of the biotechnology industry and increasing interconnectedness between entities within this market.
Our customers include medical device manufacturers and distributors, pharmaceutical companies, medical providers, government agencies, policymakers, researchers, and financial institutions.
We are developing one of the world’s most complete databases of biotech companies, technologies, conferences, scientists, grant funding, and venture capital, forming one unique Knowledge Management System that allows us to monitor trends in the industry and perform fast and precise analytics. The system allows us to create detailed models that facilitate predictive decision making.
Our company uses innovative analytic tools to connect huge amounts of complex data on diseases, treatments, costs and outcomes. We help our clients operate more efficiently.
Relying on a large pool of information, as well as on insights from billions of financial transactions pertaining to biotechnology and regenerative medicine, Aging Analytics’ databases drive results for hundreds of clients globally.
Aging Analytics Agency tracks every bit of available data on these companies, including their financials, personnel, and coverage in the media. Our company also covers all venture investments in biotechnology and regenerative medicine over the last 30 years.